Nervous system and Fabry disease, from symptoms to diagnosis: Damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy

40Citations
Citations of this article
85Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The X-linked genetic Fabry disease causes multiorgan lesions due to intracellular storage of the substrate globotriaosylceramide. Neurological involvement ranges from painful, small fiber neuropathy to cerebrovascular disorders to multifocal aggressive forms. Disease identification through proper differential diagnosis and timely assessment of organ damage should guide a careful treatment planning. Mainstay treatment, include enzyme replacement and support therapy. Neurologists have a pivotal role in early instrumental and clinical detection of organ damage. A panel of experts has developed a set of consensus recommendations to guide the approach of neurologists to Fabry disease. © The Author(s) 2010.

Cite

CITATION STYLE

APA

Salviati, A., Burlina, A. P., & Borsini, W. (2010, June). Nervous system and Fabry disease, from symptoms to diagnosis: Damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy. Neurological Sciences. https://doi.org/10.1007/s10072-009-0211-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free